Samples were collected from 36 cats with feline herpesvirus (FHV-1)-related ocular disease (conjunctivitis, epithelial or stromal keratitis, or corneal sequestration), and 17 cats without ocular changes. Corneoconjunctival swabs, scrapings and biopsies were tested in various combinations for presence of FHV-1 DNA using single round (sr) polymerase chain reaction (PCR) and nested PCR (nPCR). Additional swabs from the inferior conjunctival fornix were tested by enzyme-linked immunosorbent assay for Chlamydophila felis antigen. Cytologic evaluation was carried out on conjunctival (cats with conjunctivitis) and corneal (cats with keratitis) cytobrush preparations. FHV-1 DNA was detected by PCR in 14 (39%) cats with ocular disease and 1 (6%) of the control group. Agreement between srPCR and nPCR results was significant (P < 0.01). FHV-1 DNA was detected in 3/7 cats with conjunctivitis, 5/6 cats with epithelial keratitis, 3/11 cats with stromal keratitis, and 3/12 cats with corneal sequestration. There was a significant association (P = 0.0027) between viral presence and epithelial keratitis. However, no significant association was found between viral presence and conjunctivitis (P = 0.059), stromal keratitis (P = 0.15), or corneal sequestration (P = 0.18). With respect to FHV-1 DNA detection, intersample agreement was significant (P < 0.03). No sampling technique seemed more likely than another to harvest detectable viral DNA, except for cats with corneal sequestrum in which viral DNA was not detected using corneoconjunctival swabs. FHV-1 DNA was detected in 6/9 samples with intranuclear inclusion bodies and in 6/7 cats with eosinophils on cytologic examination. All samples tested negative for C. felis antigen.

Faeces of 230 calves with and without diarrhoea collected during the winter period 2004/2005 in 100 Austrian farms (Styria and Lower Austria) were examined for viral, bacterial and parasitic enteropathogens. Torovirus-specific nucleic acid confirmed by reverse transcriptase-polymerase chain reaction was found in 12 of 230 calves (5.2%). Ten of these calves were clinically ill, several of them showing signs of dehydration and abnormal faecal consistency at the time of sampling. Computer assisted analysis of two nucleotide sequences obtained from Austrian bovine samples revealed 93% similarity to Breda strain, but only 71% or 52% similarity to Equine Berne or Porcine Markelo torovirus strains respectively. Phylogenetic analysis grouped Austrian torovirus samples into the Bovine torovirus cluster indicating the first detection of Bovine torovirus in Austria. In addition, the following agents were detected in bovine faecal samples: Bovine coronavirus, 25.7%; Escherichia coli, 17%; Cryptosporidium spp., 11.7%; Eimeria spp., 10.4%; Rotavirus, 9.1%; Clostridium perfringens, 9.1% and Giardia spp., 6.1%. Salmonella spp. was not detected.

A hospital-based case study was conducted at the University of Veterinary Medicine Vienna for a 1-year period. The purpose of this study was to determine possible alterable and non-alterable risk factors of equine colic in Austria. The investigated parameters were obtained from hospital medical records (individual factors, duty of the horse, deworming, change in diet and water intake), from questionnaires (feed intake, watering types, housing and pasture practices) and from http://www.orf.at (weather-related factors). Moreover, 221 collected feed samples were investigated through hygienic quality sensory evaluation and mould, yeast and bacteria presumptive samples were confirmed by microbiological investigation. Variables that were observed from the hospital medical records and found to be significantly associated with colic in a univariate analysis were included in multivariate analysis and the only remaining risk factor was decreased water consumption (p < 0.001, OR = 5.025). Consequently, a total of 2743 horses and 366 cases of colic were observed during the study period. The risk factors for colic in Austria were identified for the first time in this study and these increased risk factors were decreased water consumption, high amount of concentrate intake (p = 0.037), low hygienic quality of hay (p = 0.027) and high temperature on the arrival date (p = 0.003). Results suggest that the occurrence of colic may not stop, but may decrease with better feed management practices in Austria.

No abstract

Faecal samples from 230 diarrhoeic and healthy calves aged 0-6 weeks, from 100 farms in Austria, were examined between October 2004 and February 2005 for the presence of bacteria, especially Shiga toxin-producing Escherichia coli (STEC), viruses and parasites. Escherichia coli was detected in 17% of all the faecal samples and was more prevalent in healthy calves. However, E. coli F5 was identified only in one calf without diarrhoea. Overall, 35 out of the 230 (15.2%) samples analyzed carried the Shiga toxin gene: stx1, stx2 or both stx1 and stx2 in their faeces, STEC. Nevertheless, out of 39 pathogenic E. coli positive samples observed, only two carried the Shiga toxin genes: stx1, in a diarrhoeic calf and both stx1 and stx2 in a healthy calf. eaeA and Ehly genes were detected more frequently in the strains from diarrhoeic calves 57.1% and 50.0%, respectively. Clostridium perfringens was detected in twenty-one samples, the most prevalent toxin type of Clostridium perfringens was found to be type A (76.2%). Other bacteria such as Klebsiella spp. and Proteus spp. were present in 1.3% and 0.4% of all samples. Salmonella spp. was not detected. The detection rates of other enteropathogens were 25.7% bovine coronavirus, 11.7% Cryptosporidium spp., 10.4% Eimeria spp., 9.1% group A rotavirus and Giardia spp. 6.1%. We demonstrated the presence of the STEC virulence genes in healthy and diarrhoeic Austrian calves but the importance of the virulence factors of STEC (stx1, stx2, eae and Ehly) in calf diarrhoea and systemic disease is not well defined. Therefore, further studies are necessary to identify reservoirs or potential sources of virulent STEC strains in order to establish control and prevention strategies for STEC associated diseases in animals and humans.